Musculoskeletal Disorders
Guidelines
Myositis guidelines aim to standardize adult and pediatric care
These are the first guidelines on how to manage adult and pediatric patients with idiopathic inflammatory myopathies (IIM).
Feature
‘Goodie bag’ pill mill doctor sentenced to 2 decades in prison
Regardless of the patients’ complaints, the internist gave them tote bags with prescription drugs, including muscle relaxers, anti-inflammatories...
Conference Coverage
‘Where does it hurt?’: Primary care tips for common ortho problems
An accurate diagnosis of the underlying cause of discomfort is key to appropriate management of knee and shoulder pain.
From the Journals
Surgery shows no survival, morbidity benefit for mild hyperparathyroidism
A decade-long randomized trial shows nearly identical outcomes in most measures in patients with mild parathyroid tumors who did and did not...
From the Journals
Denosumab boosts bone strength in glucocorticoid users
Compared with risedronate, denosumab promoted bone strength in patients initiating glucocorticoids and those on long-term therapy.
Feature
Doctors treat osteoporosis with hormone therapy against guidelines
Some postmenopausal women may be appropriate candidates for the use of hormone therapy for the prevention of osteoporosis and fractures.
Feature
Eighteen-year study shows inconsistencies in treating, classifying JIA
A long-term study of children with juvenile idiopathic arthritis highlights an inconsistent classification system and hints about how they manage...
From the Journals
Bone risk: Is time since menopause a better predictor than age?
The amount of time since a woman’s final menstrual period factors into bone density and fracture risk, in some cases with an even stronger...
Conference Coverage
Oral PTH shows promise for osteoporosis in early phase 2 study
The most likely patients for oral PTH, he added, “are those that have osteoporosis, previous fracture, or very low BMD, particularly those...
Conference Coverage
Could the osteoporosis drug alendronate ward off diabetes?
‘This is an interesting retrospective analysis, but it should be verified with other data such as a meta-analysis from clinical trials of...
News from the FDA/CDC
Three JAK inhibitors get boxed warnings, modified indications
The FDA is limiting all approved uses of tofacitinib, baricitinib, and upadacitinib to patients who have not responded well to TNF blockers, to...